Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 4
2019 6
2020 5
2021 10
2022 10
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
IMPACT OF MESALAZINE ON THE RESPONSE TO COVID-19 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. RESULTS OF A PROSPECTIVE MULTICENTRE STUDY OF GETECCU (VACOVEII STUDY).
Deza DC, Julián Gomara AB, Biota EC, Beltrán B, Domènech E, Casbas AG, Mañosa M, Zabana Y, Alfaro LR, Romero EV, González EG, Sicilia B, Laredo V, Alcalá Escriche MJ, Velázquez LM, Iglesias RF, Pérez AP, Calafat M, Iturria SR, Yudego IM, Nieto YB, Mateo SG, Gisbert JP, Lidón RV, Arias L, Alfambra E, Roche PC, de Acosta MB, López SG. Deza DC, et al. Gastroenterol Hepatol. 2024 Jan 12:S0210-5705(24)00017-7. doi: 10.1016/j.gastrohep.2023.12.012. Online ahead of print. Gastroenterol Hepatol. 2024. PMID: 38219960 English, Spanish.
Screening and risk of hepatocellular carcinoma in patients with advanced fibrosis after hepatitis C virus eradication.
Espina Cadena S, Casas Deza D, Julián Gomara B, Borao Laguna CV, Sierra Gabarda O, Lamuela Calvo LJ, Lorente S, Serrano T, Arbonés Mainar JM, Bernal Monterde V. Espina Cadena S, et al. Among authors: casas deza d. Rev Esp Enferm Dig. 2024 Jan 12. doi: 10.17235/reed.2024.9945/2023. Online ahead of print. Rev Esp Enferm Dig. 2024. PMID: 38214165 Free article.
A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study).
Casas Deza D, Julián Gomara AB, Caudevilla Biota E, Beltrán B, Domènech E, Gutiérrez Casbas A, Mañosa M, Zabana Y, Roc Alfaro L, Valverde Romero E, García González E, Sicilia B, Laredo V, Alcalá Escriche MJ, Madero Velázquez L, Ferreiro-Iglesias R, Palmero Pérez A, Calafat M, Rubio Iturria S, Moraleja Yudego I, Ber Nieto Y, García Mateo S, P Gisbert J, Vicente Lidón R, Arias L, Alfambra E, Doñate Borao AB, Peña González E, Corsino Roche P, Vicuña Arregui M, Elorza A, Domínguez Cajal M, Chaparro M, Barreiro-de Acosta M, García-López S. Casas Deza D, et al. Gastroenterol Hepatol. 2023 Nov 23:S0210-5705(23)00474-0. doi: 10.1016/j.gastrohep.2023.11.004. Online ahead of print. Gastroenterol Hepatol. 2023. PMID: 38007154 English, Spanish.
Initial Management of Intra-abdominal Abscesses and Preventive Strategies for Abscess Recurrence in Penetrating Crohn's Disease: A National, Multicentre Study Based on ENEIDA Registry.
Casas Deza D, Polo Cuadro C, de Francisco R, Vela González M, Bermejo F, Blanco I, de la Serna Á, Bujanda L, Bernal L, Rueda García JL, Gargallo-Puyuelo CJ, Fuentes-Valenzuela E, Castro B, Guardiola J, Ladrón G, Suria C, Sáez Fuster J, Gisbert JP, Sicilia B, Gomez R, Muñoz Vilafranca C, Barreiro-De Acosta M, Peña E, Castillo Pradillo M, Cerrillo E, Calvet X, Manceñido N, Monfort I Miquel D, Marín S, Roig C, Marce A, Ramírez de Piscina P, Betoré E, Martin-Cardona A, Teller M, Alonso Abreu I, Maroto N, Frago S, Gardeazabal D, Pérez-Martínez I, Febles González ÁD, Barrero S, Taxonera C, García de la Filia I, Ezkurra-Altuna A, Madero L, Martín-Arranz MD, Gomollón F, Domènech E, García-López S. Casas Deza D, et al. J Crohns Colitis. 2024 Apr 23;18(4):578-588. doi: 10.1093/ecco-jcc/jjad184. J Crohns Colitis. 2024. PMID: 37930823
HLA-DQA1*05 Was Not Associated With Primary Nonresponse or Loss of Response to First Anti-TNF in Real-World Inflammatory Bowel Disease Patients.
Pascual-Oliver A, Casas-Deza D, Cuarán C, García-López S, Corsino-Roche P, Sierra-Moros E, Olier-Martínez P, González-Tarancón R, Vicente-Lidón R. Pascual-Oliver A, et al. Among authors: casas deza d. Inflamm Bowel Dis. 2023 Jul 18:izad130. doi: 10.1093/ibd/izad130. Online ahead of print. Inflamm Bowel Dis. 2023. PMID: 37462462
38 results